Skip to main content

Table 4 Change in number of virus-free patients from visit 1 to visit 2 in ITT and PP population

From: Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials

Patients

Group

Virus acquired

Virus lost

Significance

ITT (n = 236)

Placebo (n = 120)

11 (9%)

18 (15%)

n.s.

 

Carrageenan (n = 116)

4 (3%)

27 (23%)

p < 0.001

PP (n = 174)

Placebo (n = 87)

5 (6%)

12 (14%)

n.s.

 

Carrageenan (n = 87)

3 (3%)

20 (23%)

p < 0.001

  1. McNemar test within-group comparison.
Back to article page

Multidisciplinary Respiratory Medicine

ISSN: 2049-6958

Contact us